Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

No 2 (2009)

Articles

Acute glomerulonephritis -all questions are answered?

- -.

Abstract

Nowadays sporadic cases and outbursts of acute post streptococcus glomerulonephritis are still registered. Albuminuria and decrease of glomerular filtration rate can persist for a long time after clinical remission of acute glomerulonephritis is achieved. Further studies of streptococcus features, including their genetic and phenotypic variability, as well as mediators, regulating processes of inflammation response in kidney tissue, let develop more effective pathogenetic approaches for acute glomerulonephritis prevention and treatment. Today acute glomerulonephritis can be considered as one of the determinants of chronic kidney disease
Clinical nephrology. 2009;(2):4-9
pages 4-9 views

Signs, mimicking chronic glomerulonephritis activity

Moukhin N.A.

Abstract

Some clinical and laboratory features - haematuria, arterial hypertension and worsening of renal function can sometimes mimic the activity of chronic glomerulonephritis. Wrong interpretation of the signs and symptoms can lead to false clinical decisions. Innovative approaches to chronic glomerulonephritis activity monitoring include evaluation of urinary excretion of inflammatory and fibrogenic mediators, as well as immune cells and podocytes
Clinical nephrology. 2009;(2):10-16
pages 10-16 views

Ultrasound scanning of kidney: opportunities and limitations

Gendlin G.E., Ettinger O.A., Reznik E.V., Tronina O.A., Solomonova L.N., Gendlin G.E., Ettinger O.A., Resnyk E.V., Tronina O.A., Solomonova O.A.

Abstract

Principles of kidney ultrasound examination and it's diagnostic value is characterized. Approaches to the interpretation of the results of kidney ultrasound examination are described
Clinical nephrology. 2009;(2):17-25
pages 17-25 views

VOZMOZhNOSTI NEFROPROTEKTsII U PATsIENTOV S METABOLIChESKIM SINDROMOM

Nedogoda S.V.

Abstract

Along with cardiovascular complications renal impairment is one of the most prognostic unfavorable metabolic syndrom's consequence. Approaches to chronic kidney disease progression in patients with metabolic syndrome are discussed
Clinical nephrology. 2009;(2):26-30
pages 26-30 views

ACE inhibitors and nephroprotection in chronic proteinuric nephropathies

Moiseev S.V., Arutyunov G.P., Fomin V.V., Moiseev S.V., Arutyunov G.P., Fomin V.V.

Abstract

ACE inhibitors slow irreversible worsening of renal function in chronic kidney disease with proteinuria, that is due not only to their blood pressure lowering effect, but also to their ability to reduce proteinuria. The reference prove of ACE inhibitors nephroprotective action was shown in trials REIN and AASK, in which ramipril was used
Clinical nephrology. 2009;(2):31-36
pages 31-36 views

Experimental models of chronic nephropathies

Paltseva E.M.

Abstract

Experimental models are widely used to search mechanisms of kidney disease progression and highly selective target therapeutic strategies. In this review examine basic experimental models, used for glomerulopathy research - nephrotoxic nephritis, anti-Thy 1.1-nephritis, puromycin-amynonucleoside nephrosis, Haimann nephritits; for progressive renal failure: subtotal (5/6) nephrectomy: tubulointerstitial nephritis - are presented
Clinical nephrology. 2009;(2):37-42
pages 37-42 views

Beta-blockers and renal continuum

Arutyunov G.P., Oganezova L.G., Arutyunov G.P., Oganezova L.G.

Abstract

Beta-blockers can be discussed as one of the approaches to limit chronic kidney disease progression, as well as to prevent cardiovascular complications in this patients. Therapeutic opportunities of beta-blockers should be explained by their effects on pathological sympathetic overactivation
Clinical nephrology. 2009;(2):43-51
pages 43-51 views

Russian registry of resistant arterial hypertension (REGATTA): study design

Chazova I.E., Fomin V.V., Razuvaeva M.A., Vigdorchik A.V., Chazova I.E., Fomin V.V., Razuvaeva M.A., Vigdorchik A.V.

Abstract

Design of Russian Registry of Resistant Arterial Hypertension Trial (REGATTA) is described. In the REGATTA trial clinical and epidemiological features of resistant and uncontrolled arterial hypertension will be characterized, as well as efficacy of fixed combination of amlodipine and valsartan
Clinical nephrology. 2009;(2):52-54
pages 52-54 views

Determination of circulating amyloid precursor protein in diagnosis and monitoring of disease progression in systemic amyloidosis

Rameev V.V., Kozlovskaya L.V., Malinina E.A., Serova A.G., Kogarko I.N., Kogarko B.S., Lyubimova N.V., Rameev V.V., Kozlovskaya L.V., Malinina E.A., Serova A.G., Kogarko I.N., Kogarko B.S., Liubimova N.V.

Abstract

Serum amyloid A (SAA) plasma level was measured at 43 patients with chronic inflammatory diseases, including 31 patients with reactive AA-amyloidosis and 12 patients not having amyloidosis (control group). SAA-protein concentration was measured with immune-enzyme analysis (ELISA) in laboratory, corresponding to European standards. The level of immunoglobulin light chains was measured at 31 patients with AL-amyloidosis. Low plasma concentration of immunoglobulin light chains, detected with Freelite method, or its decrease after treatment, indicates relatively favorable prognosis. In contrast, high plasma level of immunoglobulin light chains show very unfavorable outcome. Increase of SAA plasma level indicates risk of nephrotic syndrome development. Conclusion. Circulating amyloid precursor concentrations can be used in monitoring of disease progression. Conclusion: plasma level measurement of amyloide's proteins-predecessors can be used for amyloidosis diagnostic and prognosis of outcomes
Clinical nephrology. 2009;(2):55-62
pages 55-62 views

Chronic kidney disease as an outcome of hemorrhagic fever with renal syndrome

Pimenov L.T., Dudarev M.V., Vasil'ev M.Y., Pimenov L.T., Dudarev M.V., Vasil'ev M.Y.

Abstract

370 reconvalescents of hemorrhagic fever with renal syndrome were examined, the follow-up period was 1 year. After 1 year, signs of chronic kidney diasease was detected in 13% of patients. The most frequent signs of chronic kidney disease were albuminuria and decrease of renal functional reserve. Conclusion. Hemorrhagic fever with renal syndrome is one of the determinants of chronic kidney disease development in general population
Clinical nephrology. 2009;(2):63-65
pages 63-65 views

Renal expression of hypoxia-induced factor-1, anemia and nephrosclerosis severity in chronic glomerulonephritis

Shvetsov M.Y., Ivanov A.A., Popova O.P., Kuznetsova A.V., Rameeva A.S., Shvetsov M.Y., Ivanov A.A., Popova O.P., Kuznetsova A.V., Rameeva A.S.

Abstract

Correlation of hypoxia-inducible factor-1α (HIF-1α) expression in kidney tissue in chronic glomeruloneohritis (GN) with nephrosclerosis severity, deterioration of renal function and anemia was studied. Chronic GN progression was correlated with morphological signs of tubulo-interstitial ischemia. Increased HIF-1α tubular production was associated with lower risk of anemia development at patients with chronic GN and nephrosclerosis. Conclusion. Production of HIF-1α by renal tubular epithelium can be considered as one of the protective mechanisms against anemia development
Clinical nephrology. 2009;(2):66-70
pages 66-70 views

Optimization of loop diuretic therapy in chronic heart failure and chronic kidney disease

Kozlovskaya L.V., Fomin V.V., Moiseev S.V., Khamkhoeva M.S.

Abstract

Association of chronic heart failure and chronic kidney disease is characterized with extremely unfavorable prognosis. Treatment in oedema in this patients can be more effective with torasemid - a loop diuretic with partial aldosterone antagonist activity
Clinical nephrology. 2009;(2):71-74
pages 71-74 views

Membranous nephropathy: how to differentiate primary and paraneoplastic variants?

Mukhin N.A., Kozlovskaya L.V., Shilov E.M., Miroshnichenko N.G.

Abstract

Membranous nephropathy with nephrotic syndrome can be paraneoplastic, especially in elderly. Approaches to differentiation of primary and paraneoplastic membranous nephropathy are discussed
Clinical nephrology. 2009;(2):75-78
pages 75-78 views

90-LET S MOMENTA OPISANIYa SINDROMA GUDPASChERA

- -.
Clinical nephrology. 2009;(2):79-79
pages 79-79 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies